Cargando…
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
IMPORTANCE: Use of antihypertensive medications that stimulate type 2 and 4 angiotensin II receptors, compared with those that do not stimulate these receptors, has been associated with a lower risk of dementia. However, this association with cognitive outcomes in hypertension trials, with blood pre...
Autores principales: | Marcum, Zachary A., Cohen, Jordana B., Zhang, Chong, Derington, Catherine G., Greene, Tom H., Ghazi, Lama, Herrick, Jennifer S., King, Jordan B., Cheung, Alfred K., Bryan, Nick, Supiano, Mark A., Sonnen, Joshua A., Weintraub, William S., Williamson, Jeff, Pajewski, Nicholas M., Bress, Adam P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800076/ https://www.ncbi.nlm.nih.gov/pubmed/35089354 http://dx.doi.org/10.1001/jamanetworkopen.2021.45319 |
Ejemplares similares
-
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Cohen, Jordana B., et al.
Publicado: (2022) -
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial
por: Ghazi, Lama, et al.
Publicado: (2023) -
New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
por: King, Jordan B., et al.
Publicado: (2023) -
Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries
por: Marcum, Zachary A., et al.
Publicado: (2023) -
Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020
por: Derington, Catherine G., et al.
Publicado: (2023)